Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Abstract

Taken together, this dataset will provide a framework for characterization and enable the selection of the optimal models for immunotherapy combinations and generate potential biomarkers for clinical evaluation in identifying responders and non-responders to immunotherapy combinations.